Diaceutics PLC
LSE:DXRX
Diaceutics PLC
LSE:DXRX
Price:
165.085
GBX
-0.55%
Market Cap:
£140.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Diaceutics PLC
LSE:DXRX
|
UK |
|
Hyosung Heavy Industries Corp
KRX:298040
|
KR |
|
T
|
TA-I Technology Co Ltd
TWSE:2478
|
TW |
|
Nippon Computer Dynamics Co Ltd
TSE:4783
|
JP |
|
Rajnish Wellness Ltd
BSE:541601
|
IN |
|
Xencor Inc
NASDAQ:XNCR
|
US |
|
Revenio Group Oyj
OTC:REVXF
|
FI |
Income Statement
Earnings Waterfall
Diaceutics PLC
Diaceutics PLC
Income Statement
Diaceutics PLC
Diaceutics PLC
Currency: GBP
| Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
13
N/A
|
13
+5%
|
14
+4%
|
16
+11%
|
20
+26%
|
22
+12%
|
24
+8%
|
26
+10%
|
32
+23%
|
34
+7%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(2)
|
(4)
|
(4)
|
(4)
|
(5)
|
|
| Gross Profit |
9
N/A
|
10
+7%
|
12
+21%
|
13
+6%
|
17
+29%
|
20
+21%
|
20
-3%
|
22
+10%
|
28
+30%
|
30
+5%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(10)
|
(11)
|
(12)
|
(13)
|
(16)
|
(21)
|
(23)
|
(26)
|
(31)
|
(32)
|
|
| Selling, General & Administrative |
(10)
|
(11)
|
(12)
|
(13)
|
(16)
|
(21)
|
(23)
|
(26)
|
(31)
|
(32)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(1)
-352%
|
1
N/A
|
0
-97%
|
1
+3 094%
|
(1)
N/A
|
(3)
-472%
|
(4)
-47%
|
(2)
+45%
|
(2)
+17%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
-83%
|
0
N/A
|
(0)
N/A
|
1
N/A
|
(0)
N/A
|
(2)
-838%
|
(4)
-54%
|
(2)
+49%
|
(2)
+13%
|
|
| Net Income | |||||||||||
| Tax Provision |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Income from Continuing Operations |
0
|
(1)
|
1
|
0
|
1
|
0
|
(2)
|
(3)
|
(2)
|
(2)
|
|
| Net Income (Common) |
0
N/A
|
(1)
N/A
|
1
N/A
|
0
-77%
|
1
+461%
|
0
-99%
|
(2)
N/A
|
(3)
-63%
|
(2)
+40%
|
(2)
+11%
|
|
| EPS (Diluted) |
0
N/A
|
-0.01
N/A
|
0.01
N/A
|
0
N/A
|
0.01
N/A
|
0
N/A
|
-0.02
N/A
|
-0.03
-50%
|
-0.02
+33%
|
-0.02
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
